RevBio, Inc.
PrivateLast Round
Grant
Oct 6, 2023
Total Funding Raised
$14.8M
Company Overview
RevBio, Inc. is a clinical-stage medical device company developing a patented, synthetic, injectable, and osteoconductive bone adhesive biomaterial called TETRANITE® for use in dental and orthopedic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevBio, Inc. Comparables
Compare RevBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theradaptive | 84% | |
| OSSIO | 77% | |
| IlluminOss Medical | 77% | |
RevBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 6, 2023 | ||||
| Grant | Sep 16, 2023 | ||||
| Grant | Jun 7, 2023 | ||||
| Strategic | Feb 14, 2023 | ||||
| Accelerator | Jun 7, 2022 | ||||
VC Round | Jun 11, 2021 |
Key People
Founding team and executive leadership
RevBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| MassChallenge Israel | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2025
Monthly visitors increased 170% MoM, reaching 8.1K.
- May 2, 2025
Monthly visitors increased 367% MoM.
RevBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RevBio, Inc.'s valuation, stock price, and market status.